Weight loss plateau on GLP-1: why it happens and what to do

What is a weight loss plateau?

A plateau is a period of 2 weeks or more during which your weight stays flat despite sticking to your treatment, nutrition and exercise routine. It's one of the most frustrating phases — but also one of the most common.

In the SURMOUNT clinical trials (tirzepatide) and STEP trials (semaglutide), the weight loss curve is never a straight line. Every participant experienced stall periods before resuming their loss. The typical pattern is: rapid loss → plateau → slower loss → plateau → and so on.

Why does it happen?

There are several biological reasons, and none of them mean the medication has stopped working:

• Metabolic adaptation: as you lose weight, your body needs fewer calories to function. Your basal metabolic rate drops. If you keep eating the same amount, you eventually reach an equilibrium where calories in ≈ calories out.
• Water retention: your body can temporarily hold on to water, masking real fat loss. Stress, hormonal shifts, sodium, poor sleep and even intense exercise all trigger retention.
• Body recomposition: if you're doing resistance training (and you should be), you may be gaining muscle while losing fat. The number on the scale doesn't move, but your body is changing.
• Dose plateau: your body adapts to the current medication dose. This is expected and accounted for in the dose-escalation protocol.

10 days without losing: is it a real plateau?

Probably not. 10 days is too soon to call it a true stall. Your weight fluctuates by 1-3 lbs daily for reasons that have nothing to do with fat:

• How much water you drank (or didn't drink).
• How much sodium you had yesterday.
• Constipation (very common on GLP-1).
• Menstrual cycle phase (women can retain 2-6 lbs before their period).
• Intense exercise (muscle inflammation holds water).

Rule of thumb: a real plateau is when your weight hasn't budged for 3-4 consecutive weeks, weighing yourself under the same conditions (morning, fasting, after using the bathroom). Before that, it's normal fluctuation.

Second month on 5 mg: what to expect

If you're on tirzepatide (Mounjaro) in your second month at 5 mg weekly, you're on an early escalation dose. Here's what the evidence says:

• The 2.5 mg and 5 mg doses are adaptation doses, not full therapeutic doses. Their primary goal is to help your body tolerate the medication with minimal side effects.
• The biggest weight loss usually happens at 7.5-10 mg (Mounjaro) or 1.7-2.4 mg (Wegovy/Ozempic).
• In SURMOUNT-1, the average weight loss at 2 months was ~5% of body weight. By week 72, it reached 20-26% on the highest doses.
• It's completely normal for weight loss to slow down or stall at 5 mg. The dose-escalation schedule is designed for exactly this.

Don't get discouraged by the pace — you're at the start of a curve that unfolds over 12-18 months.

Strategies to break through a plateau

If you've been truly stuck for more than 3-4 weeks, here are the tools at your disposal:

1. Review your nutrition

• Protein: are you hitting 1.0-1.6 g/kg per day? A protein deficit slows your metabolism and accelerates muscle loss.
• Hidden calories: sauces, cooking oils, sugary drinks, alcohol. They add up fast.
• Fiber: whole vegetables and fruits help with satiety and digestion.
• Track for 3-5 days — it can reveal patterns you don't notice from memory.

2. Move more (or differently)

• If you only do cardio, add strength training 2-3 times a week. Muscle burns more calories at rest.
• If you already lift, try varying your intensity or exercises. Your body adapts to routine.
• Increase your NEAT (non-exercise activity thermogenesis): walk more, take the stairs, stand up. It's the factor that varies most between people.

3. Prioritize sleep and stress management

• Sleeping less than 7 hours raises cortisol, which promotes water retention and resists weight loss.
• Chronic stress has the same effect. This isn't woo-woo — it's physiology.

4. Talk to your doctor about your dose

• If your protocol allows escalation and you've been stuck for 4+ weeks at your current dose, your doctor may consider moving you up to the next level.
• Don't escalate on your own — dose escalation follows a schedule and sequence for safety reasons.

5. Measure more than just weight

• Inches: measure waist, hips and thighs every 2 weeks. You may be losing volume without losing weight.
• Clothes: are they fitting looser? That's real progress.
• Energy and wellbeing: are you sleeping better, moving more easily, feeling better overall? That counts too.
• Lab work: blood glucose, HbA1c, cholesterol, triglycerides. They can improve even when the scale stays put.

What NOT to do during a plateau

• Don't stop eating. Eating too little slows your metabolism even further and accelerates muscle loss.
• Don't weigh yourself 5 times a day. Once a day, same conditions, is enough. Or better: once a week.
• Don't change your dose without your doctor. Dose escalation follows a protocol for a reason.
• Don't compare yourself to others. Genetics, body composition, hormones and dieting history mean everyone responds differently.
• Don't give up. A plateau doesn't mean the treatment isn't working. It means your body is recalibrating.

When should you be concerned?

Talk to your doctor if:

• You've gone more than 6-8 weeks without any change (weight, measurements, wellbeing) despite following your treatment correctly.
• You're gaining weight consistently.
• You're experiencing new symptoms: extreme fatigue, swelling, excessive hair loss, constant feeling of cold (these could point to a thyroid issue or another underlying cause).
• You can't tolerate dose escalation and are stuck on a low dose.

Related guides

• What to eat during GLP-1 treatment — gentle foods, plate structure and nutritional deficiencies.
• Your first weeks on GLP-1 — body aches, exercise, hair loss and more.
• 8 GLP-1 myths — what the science says about muscle, weight, thyroid and more.

Sources: SURMOUNT-1 Trial (Jastreboff et al., NEJM 2022); STEP 1 Trial (Wilding et al., NEJM 2021); Müller et al., Nature Reviews Endocrinology 2022 (metabolic adaptation); Obesity Medicine Association — Managing Weight Loss Plateaus (2025); Hall & Kahan, Lancet Diabetes Endocrinol 2018 (energy balance modeling).